156 related articles for article (PubMed ID: 26643453)
41. Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active Tuberculosis.
Tebruegge M; Dutta B; Donath S; Ritz N; Forbes B; Camacho-Badilla K; Clifford V; Zufferey C; Robins-Browne R; Hanekom W; Graham SM; Connell T; Curtis N
Am J Respir Crit Care Med; 2015 Aug; 192(4):485-99. PubMed ID: 26030187
[TBL] [Abstract][Full Text] [Related]
42. IFN-γ/TNF-α ratio in response to immuno proteomically identified human T-cell antigens of Mycobacterium tuberculosis - The most suitable surrogate biomarker for latent TB infection.
Prabhavathi M; Pathakumari B; Raja A
J Infect; 2015 Aug; 71(2):238-49. PubMed ID: 25936741
[TBL] [Abstract][Full Text] [Related]
43. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
[TBL] [Abstract][Full Text] [Related]
44. Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells.
Mazzoni A; Santarlasci V; Maggi L; Capone M; Rossi MC; Querci V; De Palma R; Chang HD; Thiel A; Cimaz R; Liotta F; Cosmi L; Maggi E; Radbruch A; Romagnani S; Dong J; Annunziato F
J Immunol; 2015 Apr; 194(7):3116-26. PubMed ID: 25740946
[TBL] [Abstract][Full Text] [Related]
45. Innate signals overcome acquired TCR signaling pathway regulation and govern the fate of human CD161(hi) CD8α⁺ semi-invariant T cells.
Turtle CJ; Delrow J; Joslyn RC; Swanson HM; Basom R; Tabellini L; Delaney C; Heimfeld S; Hansen JA; Riddell SR
Blood; 2011 Sep; 118(10):2752-62. PubMed ID: 21791427
[TBL] [Abstract][Full Text] [Related]
46. CD161(high)CD8+T cells bear pathogenetic potential in multiple sclerosis.
Annibali V; Ristori G; Angelini DF; Serafini B; Mechelli R; Cannoni S; Romano S; Paolillo A; Abderrahim H; Diamantini A; Borsellino G; Aloisi F; Battistini L; Salvetti M
Brain; 2011 Feb; 134(Pt 2):542-54. PubMed ID: 21216829
[TBL] [Abstract][Full Text] [Related]
47. Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases.
Mitsuo A; Morimoto S; Nakiri Y; Suzuki J; Kaneko H; Tokano Y; Tsuda H; Takasaki Y; Hashimoto H
Rheumatology (Oxford); 2006 Dec; 45(12):1477-84. PubMed ID: 16638798
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
49. Combined Analysis of IFN-γ, IL-2, IL-5, IL-10, IL-1RA and MCP-1 in QFT Supernatant Is Useful for Distinguishing Active Tuberculosis from Latent Infection.
Suzukawa M; Akashi S; Nagai H; Nagase H; Nakamura H; Matsui H; Hebisawa A; Ohta K
PLoS One; 2016; 11(4):e0152483. PubMed ID: 27035669
[TBL] [Abstract][Full Text] [Related]
50. TNF-α/IL-2 ratio discriminates latent from active tuberculosis in immunocompetent children: a pilot study.
Gourgouillon N; de Lauzanne A; Cottart CH; Curis E; Debord C; Guérin-El Khourouj V; Pédron B; Faye A; Sterkers G
Pediatr Res; 2012 Oct; 72(4):370-4. PubMed ID: 22797138
[TBL] [Abstract][Full Text] [Related]
51. [Interferon-Gamma Release Assays in the diagnosis of latent tuberculosis infection in clinical situations].
Borkowska D; Radzikowska E; Załęska J; Ziołkowski J; Klatt M; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2014; 82(1):39-45. PubMed ID: 24391070
[TBL] [Abstract][Full Text] [Related]
52. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection: an updated review.
Moon HW; Hur M
Ann Clin Lab Sci; 2013; 43(2):221-9. PubMed ID: 23694799
[TBL] [Abstract][Full Text] [Related]
53. Percentages of CD4+CD161+ and CD4-CD8-CD161+ T cells in the synovial fluid are correlated with disease activity in rheumatoid arthritis.
Miao J; Zhang K; Qiu F; Li T; Lv M; Guo N; Han Q; Zhu P
Mediators Inflamm; 2015; 2015():563713. PubMed ID: 25960619
[TBL] [Abstract][Full Text] [Related]
54. Regulatory T-cell subsets in response to specific Mycobacterium tuberculosis antigens in vitro distinguish among individuals with different QTF and TST reactivity.
Serrano CJ; Castañeda-Delgado JE; Trujillo-Ochoa JL; González-Amaro R; García-Hernández MH; Enciso-Moreno JA
Clin Immunol; 2015 Apr; 157(2):145-55. PubMed ID: 25728490
[TBL] [Abstract][Full Text] [Related]
55. Multi-parameter flow cytometry immunophenotyping distinguishes different stages of tuberculosis infection.
Estévez O; Anibarro L; Garet E; Martínez A; Pena A; Barcia L; Peleteiro M; González-Fernández Á
J Infect; 2020 Jul; 81(1):57-71. PubMed ID: 32330526
[TBL] [Abstract][Full Text] [Related]
56. Interferon gamma release assays: principles and practice.
Lalvani A; Pareek M
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):245-52. PubMed ID: 19783328
[TBL] [Abstract][Full Text] [Related]
57. Combined Detection of IFN-γ and Lymphocyte Subsets with Activation Indicators in the Clinical Application of Mycobacterium Tuberculosis Infection at Different Times.
Chen Y; Zhang L; Zhou C; Liu Y; Pan F; Ke Q; Chen Z
Curr Microbiol; 2023 Apr; 80(6):193. PubMed ID: 37103584
[TBL] [Abstract][Full Text] [Related]
58. PD-1, PD-L1 and PD-L2 Gene Expression on T-Cells and Natural Killer Cells Declines in Conjunction with a Reduction in PD-1 Protein during the Intensive Phase of Tuberculosis Treatment.
Hassan SS; Akram M; King EC; Dockrell HM; Cliff JM
PLoS One; 2015; 10(9):e0137646. PubMed ID: 26359860
[TBL] [Abstract][Full Text] [Related]
59. The c.503T>C Polymorphism in the Human KLRB1 Gene Alters Ligand Binding and Inhibitory Potential of CD161 Molecules.
Rother S; Hundrieser J; Pokoyski C; Kollrich S; Borns K; Blasczyk R; Poehnert D; Klempnauer J; Schwinzer R
PLoS One; 2015; 10(8):e0135682. PubMed ID: 26309225
[TBL] [Abstract][Full Text] [Related]
60. Is the T-cell-based interferon-gamma releasing assay feasible for diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country?
Dilektasli AG; Erdem E; Durukan E; Eyüboğlu FÖ
Jpn J Infect Dis; 2010 Nov; 63(6):433-6. PubMed ID: 21099095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
